Trust Company’s iShares Biotechnology ETF IBB Stock Holding History

Trust Company’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.51K	Hold	50	–	–	﹤0.01%	438
2026 Q1	$8.44K	Hold	50	–	–	﹤0.01%	447
2025 Q4	$8.44K	Hold	50	–	–	﹤0.01%	443
2025 Q3	$7.22K	Hold	50	–	–	﹤0.01%	335
2025 Q2	$6.33K	Hold	50	–	–	﹤0.01%	342
2025 Q1	$6.39K	Hold	50	–	–	﹤0.01%	357
2024 Q4	$6.61K	Hold	50	–	–	﹤0.01%	332
2024 Q3	$7.28K	Hold	50	–	–	﹤0.01%	304
2024 Q2	$6.86K	Hold	50	–	–	﹤0.01%	292
2024 Q1	$6.86K	Hold	50	–	–	﹤0.01%	295
2023 Q4	$6.79K	Hold	50	–	–	﹤0.01%	275
2023 Q3	$6.12K	Hold	50	–	–	﹤0.01%	283
2023 Q2	$6.35K	Hold	50	–	–	﹤0.01%	288
2023 Q1	$6.46K	Buy	+50	New	+$6.54K	﹤0.01%	275
2022 Q4	–	Sell	-26	Closed	-$3K	–	333
2022 Q3	$3K	Hold	26	–	–	﹤0.01%	301
2022 Q2	$3K	Hold	26	–	–	﹤0.01%	308
2022 Q1	$3K	Hold	26	–	–	﹤0.01%	319
2021 Q4	$4K	Hold	26	–	–	﹤0.01%	293
2021 Q3	$4K	Hold	26	–	–	﹤0.01%	287
2021 Q2	$4K	Hold	26	–	–	﹤0.01%	288
2021 Q1	$4K	Buy	+26	New	+$4.13K	﹤0.01%	302
2019 Q2	–	Sell	-216	Closed	-$24K	–	312
2019 Q1	$24K	Sell	216 -112	-34%	-$12.3K	0.01%	210
2018 Q4	$32K	Buy	+328	New	+$34.8K	0.02%	177

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Trust Company's IBB Position: Q2 2026 in Review

Trust Company held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 50 shares worth $9.51K. The position accounts for ﹤0.01% of the portfolio, ranked #438.

Trust Company first reported a position in IBB in Q4 2018 and has held it in 23 quarters since. The position peaked at $32K in Q4 2018. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Trust Company held 50 shares of iShares Biotechnology ETF worth $9.51K as of Q2 2026.
Trust Company left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #438 holding.
Trust Company first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 23 quarters since.
Trust Company's iShares Biotechnology ETF position peaked at $32K in Q4 2018.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.